Mark Duquette
Peter M. Sadow
Jack Lawler
Carmelo Nucera
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Human Thyroid Cancers Preclinical and Translational Research Laboratory, Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States
- 2Endocrine Service, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- 3Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Center for Vascular Biology Research (CVBR), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States
By Duquette M, Sadow PM, Lawler J and Nucera C (2013). Front. Endocrinol. 4:189. doi: 10.3389/fendo.2013.00189
In the original article, there was a mistake in Figure 1 as published. The authors note a mislabeling of the cell lines name which appeared in Fig.1 left upper panel and have corrected it, andthe loading control was replaced. This correction is not of scientific nature and does not change results and conclusions of the article. The corrected Figure 1 appears below.
The authors apologize and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
FIGURE 1
Figure 1 TSP-1, ITGα6, ITGα3, ITGβ1, and pFAK protein levels by western blot in human anaplastic thyroid cancer (ATC) cell lines with sh-GFP (green fluorescent protein, control) or knock-down of TSP-1 (#7 and #8) harboring heterozygous BRAFWT/V600E (SW1736 cells) or homozygous BRAFV600E (8505c cells).
Keywords: BRAFV600E, integrins, thyroid cancer, microenvironment, extracellular matrix, TSP-1
Citation: Duquette M, Sadow PM, Lawler J and Nucera C (2020) Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment. Front. Endocrinol. 11:596223. doi: 10.3389/fendo.2020.596223
Received: 18 August 2020; Accepted: 14 September 2020;
Published: 09 October 2020.
Edited and reviewed by: Michele Caraglia, University of Campania Luigi Vanvitelli, Italy
Copyright © 2020 Duquette, Sadow, Lawler and Nucera. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carmelo Nucera, Y251Y2VyYUBiaWRtYy5oYXJ2YXJkLmVkdQ==